Insulin Like Growth Factor 2 mRNA Binding Protein3 is a Novel Post-Transcriptional Regulator of Lung Adenocarcinoma Malignancy

被引：0
|
作者：
Ding, J. [1 ]
Zhang, L. [2 ]
Yang, H. [1 ]
Wang, W. [1 ]
Guo, L. [2 ]
Wang, X. [1 ]
机构：
[1] Taizhou Hosp Zhejiang Prov, Taizhou, Peoples R China
[2] Ningxia Med Univ, Yinchuan, Ningxia, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
IGF2BP3; lung adenocarcinoma; m6a;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.06-01
引用
收藏
页码：S500 / S500
页数：1
相关论文
共 50 条
  • [31] Insulin-like growth factor-2 mRNA-binding protein 2 facilitates post-ischemic angiogenesis by increasing the stability of fibroblast growth factor 2 mRNA and its protein expression
    Ma, Shuai
    Hu, Yiqing
    Xu, Wangguo
    Xiong, Weidong
    Xu, Xinyu
    Hou, Yajie
    Wang, Ying
    Chen, Panke
    Yang, Wenbi
    Lu, Hao
    Zhao, Yongchao
    HELIYON, 2024, 10 (17)
  • [32] Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer?
    Hu, Qinghua
    Huang, Lingjin
    Kuang, Xuyuan
    Zhang, Heng
    Ling, Guoqiang
    Chen, Xuliang
    Li, Kejiang
    Deng, Zhenghao
    Zhou, Jianhua
    CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (05) : 535 - 541
  • [33] Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer?
    Qinghua Hu
    Lingjin Huang
    Xuyuan Kuang
    Heng Zhang
    Guoqiang Ling
    Xuliang Chen
    Kejiang Li
    Zhenghao Deng
    Jianhua Zhou
    Clinical & Experimental Metastasis, 2014, 31 : 535 - 541
  • [34] Novel RNA targets regulated by insulin-like growth factor 2 mRNA-binding protein 3 (IMP-3) in human melanoma
    Chu, C.
    Syu, Y.
    Sheen, Y.
    Chu, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S25 - S25
  • [35] Insulin-like growth factor binding protein-3: relationship to the development of gastric pre-malignancy and gastric adenocarcinoma (United Kingdom)
    Zhang, ZW
    Newcomb, PV
    Moorghen, M
    Gupta, J
    Feakins, R
    Savage, P
    Hollowood, A
    Alderson, D
    Holly, JMP
    CANCER CAUSES & CONTROL, 2004, 15 (02) : 211 - 218
  • [36] Insulin-like growth factor binding protein-3: relationship to the development of gastric pre-malignancy and gastric adenocarcinoma (United Kingdom)
    Zun-Wu Zhang
    Paul V. Newcomb
    Moganaden Moorghen
    Jyoti Gupta
    Roger Feakins
    Paul Savage
    Andrew Hollowood
    Derek Alderson
    Jeff M.P. Holly
    Cancer Causes & Control, 2004, 15 : 211 - 218
  • [37] Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma
    Gigek, Carolina Oliveira
    Leal, Mariana Ferreira
    Frias Lisboa, Luara Carolina
    Oliveira Silva, Patricia Natalia
    Chen, Elizabeth Suchi
    Lima, Eleonidas Moura
    Calcagno, Danielle Queiroz
    Assumpcao, Paulo Pimentel
    Burbano, Rommel Rodriguez
    Cardoso Smith, Marilia de Arruda
    GROWTH HORMONE & IGF RESEARCH, 2010, 20 (03) : 234 - 238
  • [38] Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3
    Jin, Quanri
    Lee, Hyo-Jong
    Min, Hye-Young
    Smith, John Kendal
    Hwang, Su Jung
    Whang, Young Mi
    Kim, Woo-Young
    Kim, Yeul Hong
    Lee, Ho-Young
    CARCINOGENESIS, 2014, 35 (10) : 2232 - 2243
  • [39] A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer
    Davide Di Fusco
    Antonio Di Grazia
    Giulia Di Maggio
    Maria Teresa Segreto
    Andrea Iannucci
    Claudia Maresca
    Alessandro De Stefano
    Giuseppe Sica
    Carmine Stolfi
    Giovanni Monteleone
    Ivan Monteleone
    Cell Death & Disease, 14
  • [40] A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer
    Di Fusco, Davide
    Di Grazia, Antonio
    Di Maggio, Giulia
    Segreto, Maria Teresa
    Iannucci, Andrea
    Maresca, Claudia
    De Stefano, Alessandro
    Sica, Giuseppe
    Stolfi, Carmine
    Monteleone, Giovanni
    Monteleone, Ivan
    CELL DEATH & DISEASE, 2023, 14 (04)
12345